VolitionRx Limited announced that it will receive $100,000 in funding on March 12, 2024. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 USD | -6.54% | -8.98% | -5.16% |
May. 14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
May. 13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.16% | 60.26M | |
-36.44% | 9.2B | |
-3.29% | 3.12B | |
+19.31% | 2.8B | |
-18.71% | 2.07B | |
-22.03% | 1.59B | |
+64.58% | 1.44B | |
+34.58% | 830M | |
-7.42% | 724M | |
-25.51% | 507M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it expects to receive $0.1 million in funding